Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.

Poordad F, Lawitz E, Reddy KR, Afdhal NH, Hézode C, Zeuzem S, Lee SS, Calleja JL, Brown RS Jr, Craxi A, Wedemeyer H, Nyberg L, Nelson DR, Rossaro L, Balart L, Morgan TR, Bacon BR, Flamm SL, Kowdley KV, Deng W, Koury KJ, Pedicone LD, Dutko FJ, Burroughs MH, Alves K, Wahl J, Brass CA, Albrecht JK, Sulkowski MS, Protocol 6086 Investigators

Open source

DOI
10.1053/j.gastro.2013.07.051
Published
2013 Nov
Container
Gastroenterology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1053/j.gastro.2013.07.051,
  title = {Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.},
  author = {Poordad F and Lawitz E and Reddy KR and Afdhal NH and Hézode C and Zeuzem S and Lee SS and Calleja JL and Brown RS Jr and Craxi A and Wedemeyer H and Nyberg L and Nelson DR and Rossaro L and Balart L and Morgan TR and Bacon BR and Flamm SL and Kowdley KV and Deng W and Koury KJ and Pedicone LD and Dutko FJ and Burroughs MH and Alves K and Wahl J and Brass CA and Albrecht JK and Sulkowski MS and Protocol 6086 Investigators},
  year = {2013},
  journal = {Gastroenterology},
  doi = {10.1053/j.gastro.2013.07.051},
  url = {https://doi.org/10.1053/j.gastro.2013.07.051}
}

RIS

TY  - JOUR
TI  - Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
AU  - Poordad F
AU  - Lawitz E
AU  - Reddy KR
AU  - Afdhal NH
AU  - Hézode C
AU  - Zeuzem S
AU  - Lee SS
AU  - Calleja JL
AU  - Brown RS Jr
AU  - Craxi A
AU  - Wedemeyer H
AU  - Nyberg L
AU  - Nelson DR
AU  - Rossaro L
AU  - Balart L
AU  - Morgan TR
AU  - Bacon BR
AU  - Flamm SL
AU  - Kowdley KV
AU  - Deng W
AU  - Koury KJ
AU  - Pedicone LD
AU  - Dutko FJ
AU  - Burroughs MH
AU  - Alves K
AU  - Wahl J
AU  - Brass CA
AU  - Albrecht JK
AU  - Sulkowski MS
AU  - Protocol 6086 Investigators
PY  - 2013
JO  - Gastroenterology
DO  - 10.1053/j.gastro.2013.07.051
UR  - https://doi.org/10.1053/j.gastro.2013.07.051
ER  - 

APA

F, P., E, L., KR, R., NH, A., C, H., S, Z., SS, L., JL, C., Jr, B. R., A, C., H, W., L, N., DR, N., L, R., L, B., TR, M., BR, B., SL, F., KV, K., W, D., KJ, K., LD, P., FJ, D., MH, B., K, A., J, W., CA, B., JK, A., MS, S., & Investigators, P. 6. (2013). Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.. Gastroenterology. https://doi.org/10.1053/j.gastro.2013.07.051

Source records